Molecular diagnostics and clinical genetics plan to procure an IVDR-certified comprehensive solution for sequencing (NGS) including instruments, associated reagents, software, and service and support agreements for molecular diagnostics. The purpose of this RFI is to gather information from suppliers to map the market and identify potential solutions for a possible future procurement.
Sequencing equipment will be used in routine diagnostics for genetic and pathological analyses, including the identification of mutations, hereditary diseases, cancer-related genetic changes, and applications in precision medicine.
Affected patient groups include patients with suspected or known genetic diseases, cancer patients, and patients with rare diagnoses.

LOT-0000
RFI Sequencing Equipment.
Molecular diagnostics and clinical genetics plan to procure an IVDR-certified comprehensive solution for sequencing (NGS) including instruments, associated reagents, software, and service and support agreements for molecular diagnostics. The purpose of this RFI is to gather information from suppliers to map the market and identify potential solutions for a possible future procurement.
Sequencing equipment will be used in routine diagnostics for genetic and pathological analyses, including the identification of mutations, hereditary diseases, cancer-related genetic changes, and applications in precision medicine.
Affected patient groups include patients with suspected or known genetic diseases, cancer patients, and patients with rare diagnoses.